Day
15-16
15-16
What can we learn from Rashid's case?
Suspect early to prevent mortality2,19
Early initiation of appropriate antifungal therapy is a major
determinant of survival in patients with an IFI.2,19
determinant of survival in patients with an IFI.2,19
Liposomal Amphotericin B is less toxic than conventional
amphotericin B, particularly with respect to nephrotoxicity;
however, renal adverse reactions may still occur12,20–26
amphotericin B, particularly with respect to nephrotoxicity;
however, renal adverse reactions may still occur12,20–26
Close monitoring of electrolytes and renal function during
Liposomal Amphotericin B treatment is important, especially
at escalated doses.12,27
Liposomal Amphotericin B treatment is important, especially
at escalated doses.12,27
Liposomal Amphotericin B has a broad spectrum of activity
against most clinically relevant fungal pathogens14,15,28,29
against most clinically relevant fungal pathogens14,15,28,29
Liposomal Amphotericin B demonstrates in vitro activity
against a range of fungal pathogens, including those causing
rare and difficult-to-treat infections.14,15,28,29
against a range of fungal pathogens, including those causing
rare and difficult-to-treat infections.14,15,28,29
When a life-threatening IFI strikes in your ICU, be ready
with Liposomal Amphotericin B12
with Liposomal Amphotericin B12
